Treatment outcomes with rituximab in 100 patients with neuromyelitis optica: Influence of FCGR3A polymorphisms on the therapeutic response to rituximab - Kim, S H; Jeong, I H; Hyun, J W (JAMA Neurol, 2015)
et al.